Search details
1.
Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study.
Rheumatology (Oxford)
; 2024 Jun 04.
Article
in English
| MEDLINE | ID: mdl-38833673
2.
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.
Br J Clin Pharmacol
; 2024 Apr 08.
Article
in English
| MEDLINE | ID: mdl-38589944
3.
JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications.
Ann Rheum Dis
; 82(8): 1059-1067, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37247942
4.
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying antirheumatic drugs: does line of therapy matter?
Rheumatology (Oxford)
; 2023 Sep 27.
Article
in English
| MEDLINE | ID: mdl-37758229
5.
Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England.
Rheumatology (Oxford)
; 62(7): 2426-2434, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-36355461
6.
COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohort.
Rheumatology (Oxford)
; 62(9): 2979-2988, 2023 09 01.
Article
in English
| MEDLINE | ID: mdl-36645234
7.
Implementing treat-to-target urate-lowering therapy during hospitalisations for gout flares.
Rheumatology (Oxford)
; 2023 Oct 31.
Article
in English
| MEDLINE | ID: mdl-37929968
8.
Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey.
Br J Dermatol
; 188(5): 610-617, 2023 04 20.
Article
in English
| MEDLINE | ID: mdl-36763806
9.
Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit.
Rheumatology (Oxford)
; 61(2): 734-742, 2022 02 02.
Article
in English
| MEDLINE | ID: mdl-33982063
10.
Worse outcomes linked to ethnicity for early inflammatory arthritis in England and Wales: a national cohort study.
Rheumatology (Oxford)
; 62(1): 169-180, 2022 12 23.
Article
in English
| MEDLINE | ID: mdl-35536178
11.
Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection.
Clin Exp Rheumatol
; 40(2): 329-338, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35225218
12.
Improving outcomes for patients hospitalized with gout: a systematic review.
Rheumatology (Oxford)
; 61(1): 90-102, 2021 12 24.
Article
in English
| MEDLINE | ID: mdl-34247233
13.
Disease activity and its predictors in early inflammatory arthritis: findings from a national cohort.
Rheumatology (Oxford)
; 60(10): 4811-4820, 2021 10 02.
Article
in English
| MEDLINE | ID: mdl-33537759
14.
A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritis.
Rheumatology (Oxford)
; 60(10): 4450-4462, 2021 10 02.
Article
in English
| MEDLINE | ID: mdl-34003970
15.
Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register.
Rheumatology (Oxford)
; 59(9): 2563-2571, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-31998962
16.
Variation and implications of treatment decisions in early rheumatoid arthritis: results from a nationwide cohort study.
Rheumatology (Oxford)
; 59(8): 2035-2042, 2020 08 01.
Article
in English
| MEDLINE | ID: mdl-31803913
17.
Defining and measuring imaging appropriateness in low back pain studies: a scoping review.
Eur Spine J
; 29(3): 519-529, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31938944
18.
IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study.
Rheumatology (Oxford)
; 63(4): e118-e119, 2024 Apr 02.
Article
in English
| MEDLINE | ID: mdl-37975855
19.
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis.
Rheumatology (Oxford)
; 58(10): 1755-1766, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-30982883
20.
Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Rheumatology (Oxford)
; 58(10): 1767-1776, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-30982886